Denali Therapeutics Inc.

NASDAQ: DNLI · Real-Time Price · USD
14.70
0.48 (3.38%)
At close: Jun 06, 2025, 3:59 PM
14.46
-1.63%
After-hours: Jun 06, 2025, 05:18 PM EDT

Denali Therapeutics Revenue

Denali Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Denali Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
443
Market Cap
2.14B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.